Keyphrases
Comorbidity
100%
COVID-19
94%
Asthma
69%
Population-based
65%
Primary Care
60%
Scotland
57%
Confidence Interval
44%
Spain
35%
Meta-analysis
35%
Cardiovascular Disease
34%
Germany
31%
Hospitalization
31%
Chronic Obstructive Pulmonary Disease
31%
Older People
30%
Nested Case-control Study
29%
Type 2 Diabetes Mellitus (T2DM)
29%
Electronic Health Records
29%
External Validation
28%
Interrupted Time Series Regression
26%
South Korea
26%
Population Cohort Study
26%
Multinational Network
26%
Sectional Analysis
26%
Hazard Ratio
26%
Acute Kidney Injury
25%
Fluoroquinolones
25%
Competing Risks
24%
COVID-19 Pandemic
23%
Incidence Rate
23%
Time Series Regression Analysis
22%
France
22%
European Medicines Agency
22%
Beta-blockers
22%
International Networks
22%
Risk Prediction Tool
21%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
21%
Europe
21%
COVID-19 Patients
20%
Clinical Practice Research Datalink
20%
Retrospective Cohort Study
20%
Randomized Controlled Trial
19%
Influenza
19%
Label Change
19%
Cardiovascular Risk Prediction
19%
Chronic Obstructive Pulmonary Disease Patient
19%
Performance Prediction
19%
Methodological Considerations
19%
Respiratory Effects
19%
People with Dementia
19%
Interrupted Time Series
19%
Medicine and Dentistry
COVID-19
87%
Cohort Analysis
76%
Primary Health Care
60%
Comorbidity
57%
Cardiovascular Disease
41%
Medicine
36%
Diseases
35%
Cohort Effect
33%
Cross Sectional Study
32%
Multiple Chronic Conditions
30%
Randomized Controlled Trial
29%
Maturity Onset Diabetes of the Young
27%
Time Series Analysis
27%
Cardiovascular System
27%
Systematic Review
26%
Electronic Health Record
25%
Cardiovascular Risk
21%
Acute Kidney Injury
21%
Observational Study
20%
Clinical Population
19%
Prevalence
19%
Odds Ratio
17%
Apoplexy
17%
Chronic Obstructive Pulmonary Disease
15%
Hazard Ratio
15%
Pharmacovigilance
15%
Thrombosis
15%
Thrombocytopenia
13%
Symptomatic Treatment
13%
Human Immunodeficiency Virus
13%
Hip Fracture
13%
Fragility Fracture
13%
Pancreas Cancer
13%
Antidepressant
12%
General Medicine
12%
Sulfonylurea
12%
Glycon
11%
Clinical Guideline
11%
Meta-Analysis
11%
Clinical Trial
11%
Malignant Neoplasm
11%
Adverse Event
11%
Health Outcomes
10%
Mental Health
10%
Glucagon-Like Peptide-1 Agonist
10%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Decision Making
10%
Asthma
10%
Pressure Control
9%
Chronic Pain
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
89%
Diseases
57%
Asthma
55%
Cardiovascular Disease
36%
Coronavirinae
35%
Prevalence
33%
Comorbidity
31%
Quinolone Derivative
28%
Case-Control Study
28%
Randomized Controlled Trial
27%
Observational Study
26%
Pharmacovigilance
26%
Chronic Obstructive Lung Disease
24%
Acute Kidney Failure
24%
Non Insulin Dependent Diabetes Mellitus
24%
Fragility Fracture
19%
Beta Adrenergic Receptor Blocking Agent
19%
Antipsychotic
19%
Antidepressant
19%
Adverse Event
19%
Thrombosis
17%
Multiple Chronic Conditions
16%
Cross-Sectional Study
14%
Non-Steroidal Anti-Inflammatory Drug
14%
Antibiotics
14%
Hydroxychloroquine
13%
Thrombocytopenia
13%
Dipeptidyl Carboxypeptidase Inhibitor
13%
Drug Utilization
13%
Risk Communication
13%
Tendon Rupture
13%
Hip Fracture
13%
Diclofenac
13%
Drug Development
13%
Bisphosphonic Acid Derivative
12%
Cerebrovascular Accident
11%
Monotherapy
11%
SARS Coronavirus
11%
Sulfonylurea
11%
Azithromycin
10%
Pandemic
10%
Analgesic Agent
10%
Infection
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Diuretics
9%
Congestive Heart Failure
9%
COVID-19 Vaccine
9%
Venous Thromboembolism
9%
Anticoagulant Agent
9%
Kidney Disease
8%